Cargando…
Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577116/ https://www.ncbi.nlm.nih.gov/pubmed/33117183 http://dx.doi.org/10.3389/fphar.2020.598261 |
| _version_ | 1783598145532329984 |
|---|---|
| author | Ravegnini, Gloria Del Re, Marzia Grolla, Ambra A. van Schaik, Ron H. N. Angelini, Sabrina |
| author_facet | Ravegnini, Gloria Del Re, Marzia Grolla, Ambra A. van Schaik, Ron H. N. Angelini, Sabrina |
| author_sort | Ravegnini, Gloria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7577116 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75771162020-10-27 Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response Ravegnini, Gloria Del Re, Marzia Grolla, Ambra A. van Schaik, Ron H. N. Angelini, Sabrina Front Pharmacol Pharmacology Frontiers Media S.A. 2020-10-07 /pmc/articles/PMC7577116/ /pubmed/33117183 http://dx.doi.org/10.3389/fphar.2020.598261 Text en Copyright © 2020 Ravegnini, Del Re, Grolla, van Schaik and Angelini http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Ravegnini, Gloria Del Re, Marzia Grolla, Ambra A. van Schaik, Ron H. N. Angelini, Sabrina Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title | Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title_full | Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title_fullStr | Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title_full_unstemmed | Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title_short | Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response |
| title_sort | editorial: liquid biopsy as a tool for precision oncology: new challenges to assess clinical response |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577116/ https://www.ncbi.nlm.nih.gov/pubmed/33117183 http://dx.doi.org/10.3389/fphar.2020.598261 |
| work_keys_str_mv | AT ravegninigloria editorialliquidbiopsyasatoolforprecisiononcologynewchallengestoassessclinicalresponse AT delremarzia editorialliquidbiopsyasatoolforprecisiononcologynewchallengestoassessclinicalresponse AT grollaambraa editorialliquidbiopsyasatoolforprecisiononcologynewchallengestoassessclinicalresponse AT vanschaikronhn editorialliquidbiopsyasatoolforprecisiononcologynewchallengestoassessclinicalresponse AT angelinisabrina editorialliquidbiopsyasatoolforprecisiononcologynewchallengestoassessclinicalresponse |